VHVerena Henkel

Verena Henkel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Verena Henkel has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences

    by Verena Henkel, Roland Mergl, James C. Coyne, Ralf Kohnen, Antje-Kathrin Allgaier, Elke Rühl, Hans-Jürgen Möller, Ulrich Hegerl


  • Screening for depression in primary care: Will one or two items suffice?

    by Verena Henkel, R. Mergl, J. C. Coyne, R. Kohnen, H.-J. Möller, U. Hegerl

    Small differences in implementation of screening and the associated burden on clinicians and patients could have substantial effects on the sustainability of screening in routine primary care. Therefore, we investigated the psychometric properties of single items and two–item combinations of the “WHO-5 Well Being Index” (WHO-5) and compared the obtained characteristics to those of the original version as well as to another proposed two–item screener (developed from PRIME–MD and BPHQ, respectively). Screening and diagnostic interview data from 431 primary care patients were analysed. Main outcome measures were sensitivity, specificity and AUC values. All test characteristics were assessed using the diagnoses derived from the Composite International Diagnostic Interview (CIDI) as the criterion standard. Single–item screening questions proved rather inadequate. However, only marginal differences in performance were found between two questions and the longer screening instrument with respect to major depression, dysthymia and “any depressive disorder”. There were no statistically significant differences between these AUC values and most other test characteristics assessed. The results suggest that screening could be reduced to two questions with a potential advantage in terms of ease of administration and scoring and decreased staff and patient burden and perhaps a reduced stigma associated with a positive screening score.


  • Kinematical Analysis of Motor Function in Schizophrenic Patients: a Possibility to Separate Negative Symptoms from Extrapyramidal Dysfunction Induced by Neuroleptics?

    by Verena Henkel, Roland Mergl, Martin Schäfer, Dan Rujescu, Hans-Jürgen Möller, Ulrich Hegerl

    Background: In this prospective matched case-control study, hand movement analysis was conducted using a digitizing tablet (kinematical analysis). Methods: The study examined the association of different computer-assessed hand movement variables with clinical pathology (negative symptoms and extrapyramidal motor dysfunction). A sample of 16 schizophrenic patients and 16 healthy controls participated in the study. Results: At baseline, kinematical analysis indicated a significant higher prevalence of subtle hand motor dysfunction in unmedicated schizophrenic patients (who all exhibited clinically no extrapyramidal dysfunction) in comparison to healthy controls. No association between the observed motor signs and pre-enrollment total long-term butyrophenones exposure has been detected. After 14 days treatment with haloperidol, the hand movement variables, which correlated significantly with clinical rating scores reflecting drug-induced extrapyramidal dysfunction could definitely be separated from the hand movement variables with a close association to clinical rating measuring negative symptoms. Conclusions: Results of the comparative analysis at baseline confirm previous findings concerning presence of neurological soft signs in unmedicated schizophrenic patients. Furthermore, results of this pilot study suggest that kinematical analysis by means of a digitizing tablet could be a useful approach towards a differentiation between drug-induced akinetic symptoms and disease-induced negative symptoms.


  • Use of brief depression screening tools in primary care: consideration of heterogeneity in performance in different patient groups

    by Verena Henkel, Roland Mergl, Ralf Kohnen, Antje-Kathrin Allgaier, Hans-Jürgen Möller, Ulrich Hegerl


  • Identifying depression in primary care: a comparison of different methods in a prospective cohort study

    by Verena Henkel, Roland Mergl, Ralf Kohnen, Wolfgang Maier, Hans-Jürgen Möller, Ulrich Hegerl

    Eighteen primary care facilities participated in our prospective cohort study. The study protocol was approved by our local ethics committee. On one given day, all patients who presented in one of the practices were asked to complete the three screening questionnaires before seeing a doctor. The doctors who treated the patients remained blind to the questionnaire results until they had completed a brief “physician's encounter form” to indicate their clinical assessment of their patient's current diagnoses.


  • Screening for depression in adult acne vulgaris patients: tools for the dermatologist

    by Verena Henkel, Matthias Mœhrenschlager, Ulrich Hegerl, Hans‐Jürgen Mœller, Johannes Ring, Wolf‐Ingo Worret

    Summary  Background  Adult dermatological out patients have a 40% prevalence of psychiatric co‐morbidity. If psychiatric co‐morbidity is unrecognized, undetected and untreated, the consequences may be fatal. Acne is the most common skin disorder of the second and third decades of life. Acne and its treatments may cause depression.Aims  To identify a screening tool to identify depression in adult acne patients.Methods  The literature was reviewed to identify validated screening instruments for depressive disorders. Questionnaires studied included the Hospital Anxiety and Depression Scale (HAD), the Brief Patient Health Questionnaire (B‐PHQ), the General Health Questionnaire‐12 item version (GHQ‐12), and the World Health Organization‐5 Well Being Index (WHO‐5).Results  WHO‐5 performed best in terms of sensitivity (0.93 for a cut‐off score of 13) as well as taking least time to complete (2–5 min) and evaluate (0.5–2 min).Conclusions  WHO‐5 can be recommended as part of a two‐step screening process for depression in acne patients. Step 1 is the WHO‐5. In the case of a positive score, step 2 is a detailed psychosocial assessment.


  • Cognitive-behavioural theories of helplessness/hopelessness: Valid models of depression?

    by V. Henkel, P. Bussfeld, H.-J. Möller, U. Hegerl

    Helplessness and hopelessness are central aspects of cognitive-behavioural explanations for the development and persistence of depression. In this article a general overview concerning the evolution of those approaches to depression is provided. Included is a critical examination of the theories. The review of the literature suggests that those cognitive models describing helplessness/hopelessness as trait factors mediating depression do not really have a strong empirical base. The majority of those studies had been conducted in healthy or only mildly depressed subjects. Thus, there seems to be little justification for broad generalisations beyond the populations studied. It seems that some of the reported studies have not tested the underlying theories adequately (e. g. correlation had sometimes been interpreted as causation; adequate prospective longitudinal study designs had seldom been applied). Moreover, the theoretical models are not generally prepared to explain all depressive features (e. g. the possibility of a spontaneous shift in a manic episode). Despite those limitations, there is a relevant impact of the learned helplessness paradigm on preclinical research in neurobiological correlates of depressive states. Last but not least, the models are of high interest with respect to the theoretical background of important modules of cognitive-behavioural therapy and its acute and prophylactic effects.